Using the tools of modern human genetics, the scientific community is learning how variations in different genes may impact disease at an unprecedented pace.
We believe that we are pioneering the effort to translate genetic insights into therapeutic innovations by leveraging the technological convergence between biological sciences and information technology, and that our approach to drug discovery and development significantly mitigates its inherent risks with the key feature of variant functionalization.
Our strategy focuses on advancing precision medicines to address common diseases across renal and cardio-metabolic indications. To do this, we are applying insights in genetics, combined with our area expertise and Maze Compass™ platform to maximize the long-term impact we can have on worldwide human health.
